MedImmune

MedImmune

Leading Global Biologics R&D | MedImmune.

HQ location
Gaithersburg, United States
Website
medimmune.com
Launch date
Employees
501-1000 people
Enterprise value
$15.6b
Company register number
03854275
Recent deals
Corporate Venture Fund
MedImmune Ventures
https://twitter.com/medimmunehttps://www.linkedin.com/company/medimmune/
    • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Spinout

$15.6b

Valuation: $15.6b

Acquisition
Total Funding-
AstraZeneca
AstraZeneca
Nordic Biotech
Nordic Biotech(exited)
Rho Ventures
Rho Ventures(exited)
ARCH Venture Partners
ARCH Venture Partners(exited)
Mayo Clinic Ventures
Mayo Clinic Ventures(exited)
Rho Canada Ventures
Rho Canada Ventures(exited)
Maryland Industrial Partnerships
Maryland Industrial Partnerships(exited)
University of Cambridge
University of Cambridge(exited)

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit
By Country
United States 4Germany 1Switzerland 1
By Industry
Health 3Enterprise Software 1Semiconductors 1Jobs Recruitment 1Education 1
By Round
ACQUISITION 3GRANT 1SERIES B 1EARLY VC 1

Investments by MedImmune

Edit
Definiens
Definiens
ACQUISITION by MedImmune Nov 2014
ADC Therapeutics
ADC Therapeutics
exited
Allozyne
Allozyne
ACQUISITION by MedImmune Sep 2014
Amplimmune
Amplimmune
ACQUISITION by MedImmune Aug 2013
Corvidia
Corvidia
ACQUISITION by Novo Nordisk Jun 2020
MdBio Foundation
MdBio Foundation
View 20 more